Press release
Endocrine Testing Market is expanding at a CAGR of 8.50% from 2015 - 2023
The global endocrine testing market has been broadly segmented on the basis of selected tests, diagnostic technologies, end-users, and geography. This report studies the current scenario as well as future market potential for endocrine testing globally. This report comprises an elaborate executive summary, which includes a market snapshot on market dynamics of various segments and sub-segments in a precise manner. Moreover, executive summary comprises waterfall diagram, which reflects the market size of various segments in descending order.A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global endocrine testing market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis, Porter’s Five Forces analysis, and market share analysis by key players (%) operating in the endocrine testing market.
This 138 page report gives readers a comprehensive overview of the Endocrine Testing Market. Unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/endocrine-testing-market.html
Based on test, the global endocrine testing market has been segmented into estradiol (E2), Follicle Stimulating Hormone (FSH), Human Chorionic Gonadotropin (hCG), Luteinizing hormone (LH), Dehydroepiandrosterone sulfate (DHEAS), progesterone, testosterone, Thyroid Stimulating Hormone (TSH), prolactin, cortisol and insulin tests. The market for these tests has been extensively analyzed based on consistency, effectiveness, and sales revenue of the various products developed by the manufacturers. The market size and forecast in terms of USD million for each type has been provided for the period from 2013 to 2023. The report on the endocrine testing market also provides compound annual growth rate (CAGR %) for each of the market segments mentioned above for the forecast period from 2015 to 2023, considering 2014 as the base year.
Based on diagnostic technology, the global endocrine testing market has been segmented into five major technologies such as: tandem mass spectrometry, immunoassay, monoclonal and polyclonal antibody, sensor, and clinical chemistry technologies. The market for these types has been extensively analyzed based on consistency, effectiveness, and sales revenue of the various products developed by the manufacturers. The market size and forecast in terms of USD million for each product (category) has been provided for the period from 2013 to 2023. The report on the tissue engineered skin substitutes market also provides compound annual growth rate (CAGR %) for each of the market segments mentioned above for the forecast period from 2015 to 2023, considering 2014 as the base year.
Get accurate market forecast and analysis on the Endocrine Testing Market. Request a sample to stay abreast on the key trends impacting this market: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1645
The end user segmentation elucidates the global endocrine testing market by various end users that includes hospitals, commercial laboratories, ambulatory health care centers, home based tests and physician’s offices. The market for these types has been extensively analyzed based on consistency, effectiveness, and sales revenue of the various products developed by the manufacturers. The market size and forecast in terms of USD million for each product (category) has been provided for the period from 2013 to 2023. The report on the endocrine testing market also provides compound annual growth rate (CAGR %) for each of the market segments mentioned above for the forecast period from 2015 to 2023, considering 2014 as the base year.
Geographically, the global endocrine testing market has been categorized into North America, Europe, Asia Pacific, and Rest of the World. The market size and forecast for each of these regions have been provided for the period from 2013 to 2023 along with CAGR (%) for the forecast period from 2013 to 2023. The research study also incorporates the competitive scenario of major players in these regions.
A list of recommendations have been provided for new entrants to help establish a strong presence and for existing market players to increase their market shares. The report concludes with the profiles of major players in the endocrine testing market based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include F-Hoffmann La Roche, Ltd., Abbott Laboratories, DiaSorin, Agilent Technologies, Siemens Healthcare, Thermo Fisher Scientific, AB SCIEX LLC, Bio Rad Laboratories, Lab Corporation, bioMerieux, Sysmex Corporation, Ortho-clinical Diagnostics, Quest Diagnostics and Biomedical Diagnostics.
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Endocrine Testing Market is expanding at a CAGR of 8.50% from 2015 - 2023 here
News-ID: 560068 • Views: …
More Releases from Transparency Market Research

Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 …
The global solar powered agricultural dryer market, valued at US$ 1.6 billion in 2022, is projected to grow at a CAGR of 5.8% from 2023 to 2031, reaching US$ 2.4 billion by the end of 2031. Rising investments in renewable energy, growing awareness of sustainable agricultural practices, and the rapid expansion of the agricultural sector driven by population growth are key factors fueling market growth.
Uncover essential discoveries and trends from…

Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Ra …
The global Technetium‐99m Market was valued at US$ 6.0 Billion in 2023 and is projected to grow at a CAGR of 3.3% from 2024 to 2034, surpassing US$ 8.6 Billion by the end of the forecast period. Advancements in nuclear imaging infrastructure, government-backed healthcare initiatives, and an increasing demand for precise diagnostic procedures are fueling this growth.
Discover essential conclusions and data from our Report in this sample -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77100
Analysts' Viewpoint
The Technetium‐99m…

Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to …
The global Equine Diagnostic Services Market, valued at approximately US$ 168 million in 2019, is projected to expand at a compound annual growth rate (CAGR) of ~5% from 2020 to 2030, reaching around US$ 280 million by 2030. Equine diagnostic services, encompassing tests like genetic, infectious disease, and imaging diagnostics, are critical for managing horse health in veterinary hospitals, clinics, and mobile settings. The market is driven by increasing equine…

Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of …
The digital printing market is experiencing strong growth, driven by rapid technological advancements, rising demand for personalized and on-demand printing, and an increasing focus on sustainable solutions. Digital printing allows for the direct transfer of digital files onto a wide range of substrates, offering high-resolution output with greater speed and flexibility. Its adaptability has led to broad adoption across industries such as packaging, textiles, publishing, and advertising-sectors where customization, efficiency,…
More Releases for Endocrine
Endocrine Testing: A Leading Driver Behind Impact of Diabetes Prevalence on Endo …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Endocrine Testing Industry Market Size Be by 2025?
In recent times, there has been a significant expansion in the size of the endocrine testing market. The market is projected to expand from $2.55 billion in 2024 to $2.8 billion in 2025, reflecting a compound annual growth…
Evolving Market Trends In The Endocrine Peptide Test Industry: Advancements in I …
The Endocrine Peptide Test Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Endocrine Peptide Test Market Size During the Forecast Period?
The endocrine peptide test market size has grown strongly in recent years. It will grow from $9.11 billion in 2024 to…
Key Influencer in the Endocrine Testing Market 2025: Impact of Diabetes Prevalen …
What industry-specific factors are fueling the growth of the endocrine testing market?
The growing prevalence of diabetes is also expected to drive the endocrine testing market. Similar to the peptide tests, endocrine testing is crucial for diagnosing, monitoring, and managing diabetes. As the disease becomes more prevalent, especially among younger populations, the demand for these diagnostic tests increases. According to NHS data from June 2024, diabetes diagnoses in individuals under 40…
Key Influencer in the Endocrine Peptide Test Market 2025: Impact of Diabetes Pre …
What Is the Forecasted Market Size and Growth Rate for the Endocrine Peptide Test Market?
The market size for endocrine peptide tests has significantly expanded in the recent past. The growth is slated to rise from $9.11 billion in 2024 to a significant $9.97 billion in 2025. This translates to a compound annual growth rate (CAGR) of 9.5%. The expansion during the historic phase is linked to factors like increased government…
Impact of Diabetes Prevalence on Endocrine Testing Market Growth Driver: Leading …
"What Are the Projected Growth and Market Size Trends for the Endocrine Testing Market?
In the past few years, the endocrine testing market has seen a significant expansion. The market, which is worth $2.55 billion in 2024, is projected to reach $2.8 billion in the following year, growing at a compound annual growth rate (CAGR) of 9.8%. Factors contributing to this growth during the historic period include the discovery of hormones…
Endocrine Testing Market Growth Is Attributed to Increasing Prevalence of Endocr …
Endocrine testing is an important diagnostic technique used to identify endocrine hormone level in the human body. It is utilized to diagnose hormone-related illnesses. Endocrine system consists of various glands such as pituitary gland, thyroid, pancreas, hypothalamus, and adrenal glands. Hormones secreted by these glands are used to maintain various biological functions of the body. Thus, imbalance in the concentrations of hormones may lead to certain conditions. Endocrine testing is…